BioCentury
ARTICLE | Company News

Concateno, Inverness deal

June 15, 2009 7:00 AM UTC

Inverness will acquire drug abuse testing company Concateno in a cash and stock deal of about £125.1 million ($201.4 million). The price of 121.24p per Concateno share is a 13% premium to Concateno's ...